Keywords: target product profile
Toward the definition of efficacy and safety criteria for advancing gene drive-modified mosquitoes to field testingS. L. James, J. M. Marshall, G. K. Christophides, F. O. Okumu and T. Nolan, Vector Borne and Zoonotic Diseases, 2020.Mosquitoes containing gene drive systems are being developed as complementary tools to prevent transmission of malaria and other mosquito-borne diseases. As with any new tool, decision makers and other stakeholders will need to balance risks (safety) and benefits (efficacy) when ... Keywords: gene drive synthetic, policy, preferred product characteristics, risk, target product profile |
Contact
David O’Brochta
Foundation for the
National Institutes of Health
geneconvenevi@fnih.org
RSS